2026 NPPES data Pediatric Endocrinology Physician NPI 1841207412 MD
Verify on CMS →

Ayman Akkad, MD

Pediatric Endocrinology Physician in Dearborn, Michigan.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,459 in Pediatric Endocrinology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
31
Medicare Part D claims · Pediatric Endocrinology Physician avg: 151
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$366.84
8 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Ayman Akkad, MD filed 31 Medicare Part D claims in 2023 as a Pediatric Endocrinology Physician in Dearborn, Michigan, prescribing 58% generic.

31
Part D claims, 2023
58%
generic prescribing
$366.84
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Ayman Akkad, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

31 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Ayman Akkad, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Ayman Akkad, MD?

Quality data not reported

NPI registry status

Active

Issued 08/03/2006

NPI 1841207412

Primary specialty

Pediatric Endocrinology Physician

Niche

1,459 US NPIs in this specialty

Medicare Part D claims

31 79% vs specialty avg

2023 prescription claims

Specialty avg: 151

Specialty distribution in Michigan

How Pediatric Endocrinology Physician compares to other specialties among Michigan providers

Michigan providers
Behavior Technician - 21.4%Behavior Technician21.4%Clinical Social Worker - 5.8%Clinical Social Worker5.8%Student in an Organized Health Care Education/Training Program - 3.6%Student in an Organized Health Care Education/Training Program3.6%Physical Therapist - 3.4%Physical Therapist3.4%Social Worker - 3.4%Social Worker3.4%Pharmacist - 3%Pharmacist3%Pediatric Endocrinology Physician - 0%Pediatric Endocrinology Physician0%
Largest specialties in Michigan (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Endocrinology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Ayman Akkad, MD appears in the CMS NPPES registry as a Pediatric Endocrinology Physician provider holding MD credentials at 1331 MONROE ST, Dearborn, MI, 48124, with a listed phone of (313) 914-5591. NPI 1841207412 was issued on 08/03/2006.

Medicare Part D records for calendar year 2023 show 31 prescription claims written by this provider, covering N/A Medicare beneficiaries and totaling roughly $13K in drug spend, split 42% brand-name and 58% generic by claim count.

Pediatric Endocrinology Physician is a narrow specialty nationwide, with 1,459 enrolled providers across 51 states and an average of 151 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1331 MONROE ST
Dearborn, MI 48124

Provider Details

NPI 1841207412
Specialty Pediatric Endocrinology Physician
Credentials MD
Gender Male
NPI Issued 08/03/2006

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Ayman Akkad, MD. Source: openpaymentsdata.cms.gov.

Total received

$367

Largest payer

Amgen Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Michigan MI-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Ayman Akkad, MD. To verify Ayman Akkad, MD's current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Ayman Akkad, MD - brand share 42.0%
Pediatric Endocrinology Physician average

42% brand-name claims vs 58% generic, on 31 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

31
Total Claims
$13K
Total Drug Cost
N/A
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
61
Total Day Supply
1,845
Brand vs Generic
42% brand / 58% generic
Brand Drug Cost
$13K
Generic Drug Cost
$27

Patient Demographics

Average Patient Age
66.8 years
Avg HCC Risk Score
3.44

Pediatric Endocrinology Physician Overview

How Ayman Akkad, MD fits within the Pediatric Endocrinology Physician landscape nationally.

1,459
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
151
Avg Claims per Provider

Ayman Akkad, MD's 31 claims are below the specialty average of 151.

Nearby Pediatric Endocrinology Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Akkad.

Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Michigan medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Pediatric Endocrinology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Ayman Akkad, MD's specialty?
Ayman Akkad, MD specializes in Pediatric Endocrinology Physician and practices in Dearborn, Michigan. Credentials: MD.
How much does Ayman Akkad, MD prescribe under Medicare Part D?
In 2023, Ayman Akkad, MD wrote 31 Medicare Part D claims totaling $13K in drug costs for N/A beneficiaries.
Where is Ayman Akkad, MD located?
Ayman Akkad, MD is located at 1331 MONROE ST, Dearborn, MI, 48124. Phone: (313) 914-5591.
What is Ayman Akkad, MD's NPI number?
Ayman Akkad, MD's National Provider Identifier (NPI) is 1841207412, issued on 08/03/2006.
Does Ayman Akkad, MD prescribe more brand-name or generic drugs?
Ayman Akkad, MD's prescribing is 42% brand-name and 58% generic drugs by claim count, with $13K in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US?
There are 1,459 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 151 Medicare Part D claims per year.
Does Ayman Akkad, MD accept Medicare?
Ayman Akkad, MD appears in CMS Medicare data with 31 Part D claims and N/A Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Ayman Akkad, MD's credentials?
Ayman Akkad, MD's NPI is 1841207412 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.